GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

LNP development has been a headache, but without this packaging, mRNA vaccines would be nothing. “It is the unsung hero of the whole thing,” says Giuseppe Ciaramella, who was head of ...

The global lipid nanoparticles market is on the cusp of remarkable expansion, projected to grow at a CAGR of 14% through 2035, according to a recent industry analysis. Estimated to generate USD 1,144.

Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an almost miraculous protection against a virus, which killed millions around the world. Aided by expedited ...

The mRNA platform market holds significant opportunities, driven by advancements in LNP delivery systems, codon optimization, and synthetic biology tools like CRISPR-Cas9. These innovations support ...

LNP that are used today for mRNA therapies are up to 200,000-250,000 times more active than those that were originally developed for small interfering RNA therapies. In addition, the LNP has also ...

mRNA vaccines offer clear advantages and disadvantages ... “In addition, advances in delivery technologies over current gold-standard LNP approaches to improve immunogenicity and reduce dosing ...

OSE Immunotherapeutics partners with Inside Therapeutics & MiNT Laboratory to develop mRNA therapeutics and accelerate nanodrug development: Nantes, France Saturday, May 24, 2025, ...

in order to limit the unwanted stimulation of the innate immune system against the LNP and RNA construct itself.” With mRNA vaccines already receiving approval, Ziphius believes that the hurdles ...

New Ventures BC announced that twelve alumni from its annual New Ventures BC (NVBC) Competition will be pitching at Web Summit Vancouver, taking place May 28-30. They'll be competing for a $10,000 ...